CTC
TTPH

Central Trust Company’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Central Trust Company’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed – – 1331
2017
Q1 		$0 Buy
+1
New +$112 ﹤0.01% 1224

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Central Trust Company's TTPH Position: Q2 2017 in Review

Central Trust Company sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2017, closing a stake of 1 share.

Central Trust Company first reported a position in TTPH in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2017.

  • Central Trust Company reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Central Trust Company sold 1 Tetraphase Pharmaceuticals, Inc. share in Q2 2017.
  • Central Trust Company first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2017 and held it in 1 quarter.
  • Central Trust Company's Tetraphase Pharmaceuticals, Inc. position peaked at $0 in Q1 2017.
  • 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2017.

Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.